Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ENSCENSC
4 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ENSYSCE BIOSCIENCES INC

CITADEL ADVISORS LLC holds 86,193 shares of ENSC (ENSYSCE BIOSCIENCES INC), worth $24,996 as of 2026-Q2. The position was increased (+50.3% shares).

Current Value

$24,996

Current Shares

86,193

Total Value Change

-$9,412

Total Shares Change

+71,675

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
86,193
+50.3%
$24,9960.0%$0.29
18
2026-Q1
New
57,363
-
$30,8900.0%$0.51
30
2025-Q4
Exited
0
-100.0%
$00.0%$0.93
0
2025-Q3
New
14,518
-
$34,4080.0%$2.34
30

Other major holders of ENSC: ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used